These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26902195)
1. [Atypical MRI appearance of hepatic focal nodular hyperplasia]. Tang YH; Zhang F; Wang HY; Kang SH; Zhang XJ; Wang Y; Li J; Ye HY Zhonghua Yi Xue Za Zhi; 2016 Feb; 96(7):544-6. PubMed ID: 26902195 [TBL] [Abstract][Full Text] [Related]
2. Atypical focal nodular hyperplasia of the liver: imaging features of nonspecific and liver-specific MR contrast agents. Ba-Ssalamah A; Schima W; Schmook MT; Linnau KF; Schibany N; Helbich T; Reimer P; Laengle F; Wrba F; Kurtaran A; Ryan M; Mann FA AJR Am J Roentgenol; 2002 Dec; 179(6):1447-56. PubMed ID: 12438034 [TBL] [Abstract][Full Text] [Related]
3. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma]. Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944 [TBL] [Abstract][Full Text] [Related]
4. MRI of focal nodular hyperplasia (FNH) with gadobenate dimeglumine (Gd-BOPTA) and SPIO (ferumoxides): an intra-individual comparison. Grazioli L; Morana G; Kirchin MA; Caccia P; Romanini L; Bondioni MP; Procacci C; Chiesa A J Magn Reson Imaging; 2003 May; 17(5):593-602. PubMed ID: 12720270 [TBL] [Abstract][Full Text] [Related]
5. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486 [TBL] [Abstract][Full Text] [Related]
14. Focal Nodular Hyperplasia After Treatment With Oxaliplatin: A Multiinstitutional Series of Cases Diagnosed at MRI. Furlan A; Brancatelli G; Dioguardi Burgio M; Grazioli L; Lee JM; Murmura E; Lucidarme O; Strauss C; Rode A; Ronot M; Vilgrain V AJR Am J Roentgenol; 2018 Apr; 210(4):775-779. PubMed ID: 29323545 [TBL] [Abstract][Full Text] [Related]
15. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study. Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905 [TBL] [Abstract][Full Text] [Related]
16. Radiological features of focal nodular hyperplasia of the liver in children. Cheon JE; Kim WS; Kim IO; Jang JJ; Seo JK; Yeon KM Pediatr Radiol; 1998 Nov; 28(11):878-83. PubMed ID: 9799323 [TBL] [Abstract][Full Text] [Related]
17. [Typical and atypical features of focal nodular hyperplasia of the liver on helical CT images]. Zheng L; Wu PH; Shen JX; Mo YX; Xie CM; Ruan CM; Li L Ai Zheng; 2006 Jul; 25(7):861-5. PubMed ID: 16831278 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Zech CJ; Grazioli L; Breuer J; Reiser MF; Schoenberg SO Invest Radiol; 2008 Jul; 43(7):504-11. PubMed ID: 18580333 [TBL] [Abstract][Full Text] [Related]
19. Enhancement of the liver and pancreas in the hepatic arterial dominant phase: comparison of hepatocyte-specific MRI contrast agents, gadoxetic acid and gadobenate dimeglumine, on 3 and 1.5 Tesla MRI in the same patient. Kim HJ; Kim BS; Kim MJ; Kim SH; de Campos RO; Hernandes M; Semelka RC J Magn Reson Imaging; 2013 Apr; 37(4):903-8. PubMed ID: 23065959 [TBL] [Abstract][Full Text] [Related]
20. [Diagnosis and treatment of hepatic focal nodular hyperplasia: report of 114 cases]. Li AJ; Zhou WP; Wu MC Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(5):321-3. PubMed ID: 16635391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]